亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods

免疫原性 生物信息学 体外 肽 鲑鱼降钙素 降钙素 药理学 化学 计算生物学 医学 内科学 生物 生物化学 免疫学 基因 抗体
作者
Brian Roberts,Aimee E. Mattei,Kristina E. Howard,James L. Weaver,Hao Liu,Sandra Lélias,William D Martin,Daniela I. Verthelyi,Eric S. Pang,Katie J. Edwards,Anne Searls De Groot
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:15: 1363139-1363139 被引量:9
标识
DOI:10.3389/fphar.2024.1363139
摘要

Advances in synthetic peptide synthesis have enabled rapid and cost-effective peptide drug manufacturing. For this reason, peptide drugs that were first produced using recombinant DNA (rDNA) technology are now being produced using solid- and liquid-phase peptide synthesis. While peptide synthesis has some advantages over rDNA expression methods, new peptide-related impurities that differ from the active pharmaceutical ingredient (API) may be generated during synthesis. These impurity byproducts of the original peptide sequence feature amino acid insertions, deletions, and side-chain modifications that may alter the immunogenicity risk profile of the drug product. Impurities resulting from synthesis have become the special focus of regulatory review and approval for human use, as outlined in the FDA’s Center for Drug Evaluation and Research guidance document, “ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin,” published in 2021. This case study illustrates how in silico and in vitro methods can be applied to assess the immunogenicity risk of impurities that may be present in synthetic generic versions of the salmon calcitonin (SCT) drug product. Sponsors of generic drug abbreviated new drug applications (ANDAs) should consider careful control of these impurities (for example, keeping the concentration of the immunogenic impurities below the cut-off recommended by FDA regulators). Twenty example SCT impurities were analyzed using in silico tools and assessed as having slightly more or less immunogenic risk potential relative to the SCT API peptide. Class II human leukocyte antigen (HLA)-binding assays provided independent confirmation that a 9-mer sequence present in the C-terminus of SCT binds promiscuously to multiple HLA DR alleles, while T-cell assays confirmed the expected T-cell responses to SCT and selected impurities. In silico analysis combined with in vitro assays that directly compare the API to each individual impurity peptide may be a useful approach for assessing the potential immunogenic risk posed by peptide impurities that are present in generic drug products.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花的应助被犹豫的昊焱采纳,获得20
1秒前
2秒前
yehata发布了新的文献求助10
6秒前
han完成签到,获得积分10
6秒前
9秒前
慕青的应助被yehata采纳,获得10
11秒前
CC完成签到 ,获得积分10
12秒前
13秒前
13秒前
小芋发布了新的文献求助10
15秒前
阿良完成签到 ,获得积分10
17秒前
学术废物完成签到,获得积分10
18秒前
Spirit丶Fz完成签到 ,获得积分10
19秒前
伯赏诗霜发布了新的文献求助10
19秒前
wuyyuan完成签到 ,获得积分10
24秒前
追寻从寒完成签到,获得积分10
24秒前
24秒前
会撒娇的思萱完成签到,获得积分10
24秒前
丘比特的应助被心灵美的小伙采纳,获得10
25秒前
25秒前
爆米花的应助被科研通管家采纳,获得10
26秒前
Maestro_S的应助被科研通管家采纳,获得30
26秒前
26秒前
顺利毕业就好完成签到 ,获得积分10
30秒前
sinewaves发布了新的文献求助30
30秒前
31秒前
wyc完成签到 ,获得积分10
31秒前
科研通AI6.3的应助被兰兰不懒采纳,获得10
32秒前
白蒲桃完成签到 ,获得积分10
34秒前
KuaaaaF完成签到 ,获得积分10
35秒前
37秒前
Re关注了科研通微信公众号
39秒前
47秒前
sinewaves发布了新的文献求助10
50秒前
包容明辉完成签到 ,获得积分10
51秒前
自己的样子好好看完成签到,获得积分10
57秒前
58秒前
秋风的应助被万寿宫人采纳,获得20
1分钟前
大胆半双完成签到,获得积分10
1分钟前
toki完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194962
求助须知:如何正确求助?哪些是违规求助? 9580711
关于积分的说明 21872442
捐赠科研通 7794663
什么是DOI,文献DOI怎么找? 3437819
关于科研通互助平台的介绍 2561143
邀请新用户注册赠送积分活动 2484511